138 related articles for article (PubMed ID: 35819690)
1. Insight into the Crystal Structures and Potential of Two Newly Synthesized Naproxen-Based Hydrazide Derivatives as Potent COX-2 Inhibitors.
Mohamed SK; Ahmad S; Albayati MR; Elgarhy SMI; Lai CH; Mague JT; El Bakri Y
Appl Biochem Biotechnol; 2022 Dec; 194(12):5781-5807. PubMed ID: 35819690
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, crystal structure investigation and computational approach to discover potential hydrazide derivatives as a potent inhibitor of cyclooxygenase-2 enzyme.
El Bakri Y; Mohamed SK; Ahmad S; Albayati MR; Elgarhy SMI; Lai CH; Mague JT
J Biochem Mol Toxicol; 2022 Aug; 36(8):e23082. PubMed ID: 35435307
[TBL] [Abstract][Full Text] [Related]
3. Arylhydrazone derivatives of naproxen as new analgesic and anti-inflammatory agents: Design, synthesis and molecular docking studies.
Azizian H; Mousavi Z; Faraji H; Tajik M; Bagherzadeh K; Bayat P; Shafiee A; Almasirad A
J Mol Graph Model; 2016 Jun; 67():127-36. PubMed ID: 27311100
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, in-vitro, in-vivo anti-inflammatory activities and molecular docking studies of acyl and salicylic acid hydrazide derivatives.
Munir A; Khushal A; Saeed K; Sadiq A; Ullah R; Ali G; Ashraf Z; Ullah Mughal E; Saeed Jan M; Rashid U; Hussain I; Mumtaz A
Bioorg Chem; 2020 Nov; 104():104168. PubMed ID: 32947133
[TBL] [Abstract][Full Text] [Related]
5. Structural alterations based on naproxen scaffold: Synthesis, evaluation of antitumor activity and COX-2 inhibition, and molecular docking.
El-Husseiny WM; El-Sayed MA; Abdel-Aziz NI; El-Azab AS; Asiri YA; Abdel-Aziz AA
Eur J Med Chem; 2018 Oct; 158():134-143. PubMed ID: 30216848
[TBL] [Abstract][Full Text] [Related]
6. Computational Design and Biological Depiction of Novel Naproxen Derivative.
Shah K; Mujwar S; Krishna G; Gupta JK
Assay Drug Dev Technol; 2020 Oct; 18(7):308-317. PubMed ID: 32749851
[No Abstract] [Full Text] [Related]
7. Synthesis and molecular docking of new imidazoquinazolinones as analgesic agents and selective COX-2 inhibitors.
Hassanein HH; Georgey HH; Fouad MA; El Kerdawy AM; Said MF
Future Med Chem; 2017 Apr; 9(6):553-578. PubMed ID: 28394629
[TBL] [Abstract][Full Text] [Related]
8. COX Inhibition Profile and Molecular Docking Studies of Some 2-(Trimethoxyphenyl)-Thiazoles.
Oniga SD; Pacureanu L; Stoica CI; Palage MD; Crăciun A; Rusu LR; Crisan EL; Araniciu C
Molecules; 2017 Sep; 22(9):. PubMed ID: 28891941
[TBL] [Abstract][Full Text] [Related]
9. Molecular Mechanisms in the Selectivity of Nonsteroidal Anti-Inflammatory Drugs.
Shamsudin Y; Gutiérrez-de-Terán H; Åqvist J
Biochemistry; 2018 Feb; 57(7):1236-1248. PubMed ID: 29345921
[TBL] [Abstract][Full Text] [Related]
10. Aryl/heteroaryl Substituted Celecoxib Derivatives as COX-2 Inhibitors: Synthesis, Anti-inflammatory Activity and Molecular Docking Studies.
Madhava G; Ramana KV; Sudhana SM; Rao DS; Kumar KH; Lokanatha V; Rani AU; Raju CN
Med Chem; 2017; 13(5):484-497. PubMed ID: 28228088
[TBL] [Abstract][Full Text] [Related]
11. 2-Substituted Benzoxazoles as Potent Anti-Inflammatory Agents: Synthesis, Molecular Docking and In vivo Anti-Ulcerogenic Studies.
Hamid I; Nadeem H; Ansari SF; Khiljee S; Abbasi I; Bukhari A; Arif M; Imran M
Med Chem; 2022; 18(7):791-809. PubMed ID: 34931968
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological assessment of new selective COX-2 inhibitors including methyl sulfonyl moiety.
Sağlık BN; Osmaniye D; Levent S; Çevik UA; Çavuşoğlu BK; Özkay Y; Kaplancıklı ZA
Eur J Med Chem; 2021 Jan; 209():112918. PubMed ID: 33071054
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, anti-inflammatory activity, and molecular docking studies of perimidine derivatives containing triazole.
Zhang HJ; Wang XZ; Cao Q; Gong GH; Quan ZS
Bioorg Med Chem Lett; 2017 Sep; 27(18):4409-4414. PubMed ID: 28823493
[TBL] [Abstract][Full Text] [Related]
14. Novel thiazolo[3,2-b]-1,2,4-triazoles derived from naproxen with analgesic/anti-inflammatory properties: Synthesis, biological evaluation and molecular modeling studies.
Sarigol D; Uzgoren-Baran A; Tel BC; Somuncuoglu EI; Kazkayasi I; Ozadali-Sari K; Unsal-Tan O; Okay G; Ertan M; Tozkoparan B
Bioorg Med Chem; 2015 May; 23(10):2518-28. PubMed ID: 25868745
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological evaluation and preparation of nonsteroidal anti-inflammatory drugs containing an N-acyl hydrazone subunit.
de Melo TR; Chelucci RC; Pires ME; Dutra LA; Barbieri KP; Bosquesi PL; Trossini GH; Chung MC; dos Santos JL
Int J Mol Sci; 2014 Apr; 15(4):5821-37. PubMed ID: 24714090
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, Anti-Inflammatory Activity, DFT Modeling and Docking Study of New Ibuprofen Derivatives.
Abbas AM; Nasrallah HH; Aboelmagd A; Kishk SM; Boyd WC; Kalil H; Orabi AS
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542530
[TBL] [Abstract][Full Text] [Related]
17. Naproxenylamino acid derivatives: Design, synthesis, docking, QSAR and anti-inflammatory and analgesic activity.
Elhenawy AA; Al-Harbi LM; El-Gazzar MA; Khowdiary MM; Ouidate A; Alosaimi AM; Elhamid Salim A
Biomed Pharmacother; 2019 Aug; 116():109024. PubMed ID: 31150990
[TBL] [Abstract][Full Text] [Related]
18. Biology-oriented drug synthesis (BIODS), in vitro urease inhibitory activity, and in silico study of S-naproxen derivatives.
Mohiuddin G; Khan KM; Salar U; Kanwal ; Lodhi MA; Wadood A; Riaz M; Perveen S
Bioorg Chem; 2019 Mar; 83():29-46. PubMed ID: 30339862
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, anti-inflammatory antitumor activities, molecular modeling and molecular dynamics simulations of potential naprosyn® analogs as COX-1 and/or COX-2 inhibitors.
El Sayed MT; El-Sharief MAMS; Zarie ES; Morsy NM; Elsheakh AR; Nayel M; Voronkov A; Berishvili V; Sabry NM; Hassan GS; Abdel-Aziz HA
Bioorg Chem; 2018 Feb; 76():188-201. PubMed ID: 29182950
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, comparative docking, and pharmacological activity of naproxen amino acid derivatives as possible anti-inflammatory and analgesic agents.
Elhenawy AA; Al-Harbi LM; Moustafa GO; El-Gazzar MA; Abdel-Rahman RF; Salim AE
Drug Des Devel Ther; 2019; 13():1773-1790. PubMed ID: 31213767
[No Abstract] [Full Text] [Related]
[Next] [New Search]
